↓ Skip to main content

Understanding the mechanisms of aromatase inhibitor resistance

Overview of attention for article published in Breast Cancer Research, January 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
2 news outlets
twitter
1 X user

Citations

dimensions_citation
78 Dimensions

Readers on

mendeley
118 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Understanding the mechanisms of aromatase inhibitor resistance
Published in
Breast Cancer Research, January 2012
DOI 10.1186/bcr2931
Pubmed ID
Authors

William R Miller, Alexey A Larionov

Abstract

ABSTRACT: Aromatase inhibitors (AIs) have a central role in the treatment of breast cancer; however, resistance is a major obstacle to optimal management. Evidence from endocrine, molecular and pathological measurements in clinical material taken before and after therapy with AIs and data from clinical trials in which AIs have been given as treatment either alone or in combination with other targeted agents suggest diverse causes for resistance. These include inherent tumour insensitivity to oestrogen, ineffective inhibition of aromatase, sources of oestrogenic hormones independent of aromatase, activation of signalling by non-endocrine pathways, enhanced cell survival and selection of hormone-insensitive cellular clones during treatment.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 118 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Portugal 1 <1%
France 1 <1%
Unknown 116 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 23 19%
Student > Ph. D. Student 18 15%
Student > Master 17 14%
Researcher 15 13%
Student > Postgraduate 8 7%
Other 18 15%
Unknown 19 16%
Readers by discipline Count As %
Agricultural and Biological Sciences 28 24%
Medicine and Dentistry 24 20%
Biochemistry, Genetics and Molecular Biology 13 11%
Chemistry 10 8%
Pharmacology, Toxicology and Pharmaceutical Science 10 8%
Other 10 8%
Unknown 23 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 May 2023.
All research outputs
#2,147,457
of 25,373,627 outputs
Outputs from Breast Cancer Research
#199
of 2,052 outputs
Outputs of similar age
#15,519
of 251,408 outputs
Outputs of similar age from Breast Cancer Research
#1
of 40 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,052 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.2. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 251,408 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 40 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.